Literature DB >> 1583880

Effect of methylmalonate on in vitro lactate release and carbon dioxide production by brain of suckling rats.

M Wajner1, J C Dutra, S E Cardoso, C M Wannmacher, E R Motta.   

Abstract

Methylmalonate (MMA) accumulates in the tissues of patients with methylmalonic acidaemia, who present severe neurological signs soon after birth and later mental retardation. Attempting to understand the pathophysiology of the disorder, we investigated the effects of MMA on brain glucose uptake, lactate release and CO2 production. Glucose uptake and lactate release were studied by incubating 40 microns wide brain prisms from 15-day-old rats in Krebs-Ringer bicarbonate buffer, pH 7.0, containing 5.0 mmol/L glucose and one of three concentrations of MMA (1.0, 2.5 and 5.0 mmol/L). Controls did not contain MMA in the incubation medium. MMA induced a significant increase of lactate production in a dose-dependent pattern that was proportional to glucose uptake by the brain prisms. We also studied the influence of MMA on brain CO2 production from [2-14C]glucose and [U-14C]acetate by incubating brain prisms in the same buffer in the presence of the substrates with (experimental groups) or without (controls) 5.0 mmol/L MMA. MMA significantly reduced CO2 formation from both substrates.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1583880     DOI: 10.1007/bf01800350

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  9 in total

1.  Kinetics of blood-brain barrier transport of pyruvate, lactate and glucose in suckling, weanling and adult rats.

Authors:  J E Cremer; V J Cunningham; W M Pardridge; L D Braun; W H Oldendorf
Journal:  J Neurochem       Date:  1979-08       Impact factor: 5.372

2.  Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen.

Authors:  P Trinder
Journal:  J Clin Pathol       Date:  1969-03       Impact factor: 3.411

3.  Effects of methylmalonate and propionate on uptake of glucose and ketone bodies in vitro by brain of developing rats.

Authors:  J C Dutra; M Wajner; C F Wannmacher; C S Dutra-Filho; C M Wannmacher
Journal:  Biochem Med Metab Biol       Date:  1991-02

4.  The inhibition by methylmalonic acid of malate transport by the dicarboxylate carrier in rat liver mitochondria. A possible explantation for hypoglycemia in methylmalonic aciduria.

Authors:  M L Halperin; C M Schiller; I B Fritz
Journal:  J Clin Invest       Date:  1971-11       Impact factor: 14.808

5.  The estimation of rates of utilization of glucose and ketone bodies in the brain of the suckling rat using compartmental analysis of isotopic data.

Authors:  J E Cremer; D F Heath
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

6.  The rate of cerebral utilization of glucose, ketone bodies, and oxygen: a comparative in vivo study of infant and adult rats.

Authors:  G Dahlquist; B Persson
Journal:  Pediatr Res       Date:  1976-11       Impact factor: 3.756

7.  Uptake and utilization of metabolites in specific brain sites relative to feeding status.

Authors:  T R Kasser; A Deutch; R J Martin
Journal:  Physiol Behav       Date:  1986

8.  Ketone-body utilization by adult and suckling rat brain in vivo.

Authors:  R A Hawkins; D H Williamson; H A Krebs
Journal:  Biochem J       Date:  1971-03       Impact factor: 3.857

  9 in total
  10 in total

Review 1.  Mitochondrial energy metabolism in neurodegeneration associated with methylmalonic acidemia.

Authors:  Daniela R Melo; Alicia J Kowaltowski; Moacir Wajner; Roger F Castilho
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

2.  Inhibition of rat brain lipid synthesis in vitro by 4-hydroxybutyric acid.

Authors:  A R Silva; C Ruschel; C Helegda; A M Brusque; C M Wannmacher; M Wajner; C S Dustra-Filho
Journal:  Metab Brain Dis       Date:  1999-09       Impact factor: 3.584

Review 3.  Metabolic disturbances in diseases with neurological involvement.

Authors:  João M N Duarte; Patrícia F Schuck; Gary L Wenk; Gustavo C Ferreira
Journal:  Aging Dis       Date:  2013-11-30       Impact factor: 6.745

4.  Methylmalonyl-CoA mutase induction by cerebral ischemia and neurotoxicity of the mitochondrial toxin methylmalonic acid.

Authors:  P Narasimhan; R Sklar; M Murrell; R A Swanson; F R Sharp
Journal:  J Neurosci       Date:  1996-11-15       Impact factor: 6.167

5.  Progressive neurological deterioration and MRI changes in cblC methylmalonic acidaemia treated with hydroxocobalamin.

Authors:  G M Enns; A J Barkovich; D S Rosenblatt; D R Fredrick; K Weisiger; C Ohnstad; S Packman
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

Review 6.  Neurological dysfunction in methylmalonic acidaemia is probably related to the inhibitory effect of methylmalonate on brain energy production.

Authors:  M Wajner; J C Coelho
Journal:  J Inherit Metab Dis       Date:  1997-11       Impact factor: 4.982

7.  Inhibition of succinate dehydrogenase and beta-hydroxybutyrate dehydrogenase activities by methylmalonate in brain and liver of developing rats.

Authors:  J C Dutra; C S Dutra-Filho; S E Cardozo; C M Wannmacher; J J Sarkis; M Wajner
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

8.  Methylmalonate inhibits succinate-supported oxygen consumption by interfering with mitochondrial succinate uptake.

Authors:  S R Mirandola; D R Melo; P F Schuck; G C Ferreira; M Wajner; R F Castilho
Journal:  J Inherit Metab Dis       Date:  2008-01-24       Impact factor: 4.982

9.  Ganglioside alterations in the central nervous system of rats chronically injected with methylmalonic and propionic acids.

Authors:  V M T Trindade; A M Brusque; J R Raasch; L E Pettenuzzo; H P Rocha; C M D Wannmacher; M Wajne
Journal:  Metab Brain Dis       Date:  2002-06       Impact factor: 3.584

Review 10.  Glutathione as a Redox Biomarker in Mitochondrial Disease-Implications for Therapy.

Authors:  Gregory M Enns; Tina M Cowan
Journal:  J Clin Med       Date:  2017-05-03       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.